Lantern Pharma (LTRN) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.51
-0.44
-0.36
-0.29

Details

Expected EPS
-0.43
Actual EPS
-0.51
Surprise EPS
-0.08
Surprise Percent
+18.6%

Description

Lantern Pharma (LTRN) has reported earnings of -0.51 per share for Q2 2024.

0 Comments

Share your thoughts